Search Results
May 11, 2026, 08:00 ET Johnson & Johnson reinforces its leadership in advancing neuropsychiatry with new portfolio and pipeline data at APA and ASCP
for the millions of patients living with some of today's most prevalent and debilitating neuropsychiatric conditions," said Jane Tiller, FRC Psych (MD), MBA, MPhil, Vice President Global Head of Development, Neuroscience, Innovative Medicine, Johnson & Johnson. "The depth of data being presented
More news about: Johnson & Johnson
May 11, 2026, 07:45 ET CAE pursues strategic alternatives for Flightscape
the risks and uncertainties affecting CAE's business can be found in CAE's Management's Discussion and Analysis (MD&A) for the fiscal year ended March 31, 2025 and MD&A for the three months ended December 31, 2025, available on CAE's website (
More news about: CAE Inc.
May 11, 2026, 07:04 ET Biozen Receives FDA Clearance for Calibration-Free Cuffless Blood Pressure Technology
accurate.""I've watched cuffless blood pressure get announced for years, and most of it hasn't met the bar clinicians need," said Kenneth Civello, MD, cardiologist and electrophysiologist, and advisor to Biozen. "What's different about the BP1000 is that it's measuring blood pressure, not estimating
More news about: Biozen, LLC
May 11, 2026, 07:01 ET Safe, Healthy, and Happy: Practical Tips To Help Kids Who Are Deaf and Hard of Hearing Make the Most of Summer
Audiologists and Parents Offer Advice for Managing Some of the Season's Trickiest Scenarios ROCKVILLE, Md., May 11, 2026 /PRNewswire/ -- Swimming, playing outside, and traveling are central parts of the summer experience
More news about: American Speech-Language-Hearing Association (ASHA)
May 11, 2026, 07:00 ET Ceva, Inc. Announces First Quarter 2026 Financial Results
Highlights strong licensing growth driven by integrated solutions and accelerating edge AI adoptionROCKVILLE, Md., May 11, 2026 /PRNewswire/ -- Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP for
More news about: Ceva, Inc.
May 11, 2026, 06:59 ET Ceva Advances Full-Stack Wireless Vision with Next Generation Bluetooth High Data Throughput and Integrated RF Design Win
system-level wireless solutions, deepening customer partnerships across the wireless value chainROCKVILLE, Md., May 11, 2026 /PRNewswire/ -- Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP for
More news about: Ceva, Inc.
May 11, 2026, 06:08 ET cultivate(MD) Focus Fund Announces Initial Capital Deployments
it to do: deploying capital strategically behind portfolio companies who are achieving clinical and regulatory milestones," said R. Sean Churchill, MD, MBA, Managing Director of cultivate(MD). "Prana Surgical's recent FDA clearance is a meaningful win for many patients and their physicians who need a
More news about: cultivate(MD)
May 11, 2026, 06:00 ET Partner Therapeutics Announces FDA Approval of BIZENGRI® (Zenocutuzumab-zbco) for NRG1 Fusion-Positive Cholangiocarcinoma Following Receipt of FDA Commissioner's National Priority Voucher
reliably detect gene fusions such as NRG1 and ensure patients are appropriately identified for targeted therapy."— James Cleary, MD, PhD, Director of Clinical Research, Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard
More news about: Partner Therapeutics, Inc.
May 11, 2026, 04:30 ET Trial Results Support At-Home Treatment of Edema in Heart Failure with Subcutaneous Furosemide as an Effective and Safe Alternative to Inpatient Hospital Care
tolerated."The SUBCUT HF II study represents an important milestone on this path home for the many patients for whom this is an option," said Pieter Muntendam, MD founder, President and CEO of SQ Innovation, the manufacturer of Lasix ONYU. "This is the first outcomes study of home use of subcutaneous furosemide
More news about: SQ Innovation
May 10, 2026, 20:00 ET Innovent Announces IBI363 (PD-1/IL-2α-bias Bispecific Fusion Protein) Received Third NMPA Breakthrough Therapy Designation for MSS/pMMR Metastatic Colorectal Cancer
in early clinical stage. Innovent partners with over 30 global healthcare companies, including Eli Lilly, Roche, Takeda, Sanofi, Incyte, LG Chem and MD Anderson Cancer Center.Guided by the motto, "Start with Integrity, Succeed through Action," Innovent maintains the highest standard of industry
More news about: Innovent Biologics
May 10, 2026, 15:48 ET NPHI and C-TAC Launch Work on a Federal Community-Based Model to Expand Earlier, In-Home Support for Patients Nationwide
model."Nearly half of Medicare beneficiaries remain in Original Medicare, typically in a fee for service payment model," said Cameron Muir, MD, Chief Medical & Innovation Officer at NPHI. "Given the costs associated with the highest needs beneficiaries (roughly 10% of Medicare patients
More news about: National Partnership for Healthcare and Hospice Innovation
May 09, 2026, 15:12 ET AAVnerGene anuncia AAVone®2.1
único de próxima generación que logra ~1e16 GC/L y >70% de cápsides completas en la cosechaROCKVILLE, Md., 9 de mayo de 2026 /PRNewswire/ -- Estados Unidos -- AAVnerGene Inc. anunció hoy el lanzamiento de AAVone®2.1,
More news about: AAVnerGene Inc.
May 09, 2026, 09:00 ET Lumenis Aesthetics Showcases New Clinical Data Across Skin and Hair Loss Indications at 45th Annual American Society for Laser Medicine and Surgery Conference
Presenters:Dr. Isabella Camacho-Hubbard, MD; Dr. Girish Munavalli, MD, MHS — Dermatology Laser & Vein Specialists of the Carolinas, Charlotte, NC
More news about: Lumenis Be. Ltd.
May 08, 2026, 16:00 ET Marriott International Declares an Increase in Quarterly Cash Dividend
BETHESDA, Md., May 8, 2026 /PRNewswire/ -- Marriott International, Inc. (Nasdaq: MAR) today announced that its board of directors declared a quarterly cash dividend of 73 cents per share of common stock, which reflects the
More news about: Marriott International, Inc.
May 08, 2026, 12:36 ET This Mother's Day, ProCure Proton Therapy Center Urges Women to Give Themselves the Gift of Screening
earlier — or even when we find it through screening at a later stage — women have access to more options and more precise treatment." — Brian Chon, MD, Medical Director, ProCure Proton Therapy Center, SomersetFor women diagnosed with breast cancer, ProCure offers proton therapy — an advanced form
More news about: ProCure Proton Therapy Center
May 08, 2026, 10:00 ET PATROUILLE DE FRANCE TO LAUNCH HISTORIC "LIBERTÉ 250" U.S. TOUR AT AIR DOT SHOW OCEAN CITY
French Air and Space Force Aerobatic Team will begin first U.S. tour in nearly a decade next month at Ocean City, Md.OCEAN CITY, Md., May 8, 2026 /PRNewswire/ -- The Air Dot Show Tour announced today that the Patrouille
More news about: Air Dot Show
May 08, 2026, 10:00 ET 5W and Haute Living Launch the Designer AI Visibility Index, the First Audit Framework Measuring How Interior Designers and Architects Appear on ChatGPT, Claude, and Perplexity
and internationally. Through HauteLiving.com, Haute Living magazine, and an integrated network of editorial verticals — including Haute Design, Haute MD, Haute Black, Haute Residence, and HL Real Estate Group — Haute Living connects affluent readers, developers, and design professionals to the world's
More news about: 5W Public Relations
May 08, 2026, 08:17 ET AAVnerGene Announces AAVone®2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest
ROCKVILLE, Md., May 8, 2026 /PRNewswire/ -- USA -- AAVnerGene Inc. today announced the launch of AAVone®2.1, the next-generation evolution of its proprietary AAVone® single-plasmid AAV production system,
More news about: AAVnerGene Inc.
May 08, 2026, 08:15 ET SVKM's NMIMS Marks 45 Years of Excellence with Multi-Campus Convocation Celebrations Across India
Sarah Samuel, Senior Manager, Human Resources, Adidas. At Bengaluru, the ceremony was graced by Chief Guest Shri Prabhakar Varadarajan, Head GCC & MD (I), GCC Bengaluru, ANZ. The Indore convocation was graced by Chief Guest Dr. Ramesh B. Baheti, distinguished industrialist and educationist.The
More news about: SVKM’s NMIMS
May 08, 2026, 08:00 ET Atlantic Homes Company Breaks Ground on First Home in Heritage Oak Estates in Middletown, Maryland
MIDDLETOWN, Md., May 8, 2026 /PRNewswire/ -- Atlantic Homes Company, a custom home builder, today announced the groundbreaking of its first residence in the Heritage Oak Estates community in Middletown, Maryland. This milestone
More news about: Atlantic Homes Company
May 08, 2026, 07:57 ET AAVnerGene Announces AAVone®2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest
ROCKVILLE, Md., May 8, 2026 /PRNewswire/ -- USA -- AAVnerGene Inc. today announced the launch of AAVone®2.1, the next-generation evolution of its proprietary AAVone® single-plasmid AAV production system,
More news about: AAVnerGene Inc.
May 08, 2026, 06:45 ET TELUS reports operational and financial results for first quarter 2026
in Section 9 in our 2025 annual MD&A, remain the same, except for the updates below as well as our estimates regarding economic growth, inflation, unemployment and housing starts as discussed in Section 1.2 in our first quarter 2026 MD&A.Our restructuring
More news about: TELUS Corporation
May 08, 2026, 06:45 ET TELUS reports operational and financial results for first quarter 2026
in Section 9 in our 2025 annual MD&A, remain the same, except for the updates below as well as our estimates regarding economic growth, inflation, unemployment and housing starts as discussed in Section 1.2 in our first quarter 2026 MD&A.Our restructuring
More news about: TELUS Corporation
May 08, 2026, 05:08 ET Oblique Therapeutics today announced that Dr. Jan Lundberg has joined the company as Scientific Advisor
development," says Christer Nordstedt, CEO of Oblique Therapeutics.For further information, please contactChrister Nordstedt MD PhDCEOOblique Therapeutics ABBox 40091-9037Datavägen 15D436 32 AskimMobil: +46
More news about: Oblique Therapeutics AB
May 08, 2026, 05:01 ET Oblique Therapeutics today announced that Dr. Jan Lundberg has joined the company as Scientific Advisor
development," says Christer Nordstedt, CEO of Oblique Therapeutics.For further information, please contactChrister Nordstedt MD PhDCEOOblique Therapeutics ABBox 40091-9037Datavägen 15D436 32 AskimMobil: +46
More news about: Oblique Therapeutics AB